Fundraising FoxAttwill Vascular Technologies
Lodi, US · Founded 2016 · Delaware limited partnership
Find your way into Attwill Vascular Technologies
Sign up to find every way you can get introduced to Attwill Vascular Technologies
- Your email: who you already know at Attwill Vascular Technologies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Attwill Vascular Technologies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
RG
Robert Geoffrey BrowneNamed on SEC filing
JS
John SchramNamed on SEC filing
TS
Tim ShortlyNamed on SEC filing
WJ
William JacksonNamed on SEC filing
AD
Attilio DiFioreNamed on SEC filing
RM
Ricardo Michael FerreiraNamed on SEC filing
RA
Richard AbrahamNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.4M disclosed across 3 rounds · 2020–2021
▶$1.7MraisedMar 2022 · 26 investors · Other Health CareRule 506(b)
▶$1.7MraisedMar 2022 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John KennedyDirector
- Richard AbrahamDirector
- Robert Geoffery BrowneDirector
- John Timmothy ShortlyDirector
- Ricardo FerreiraDirector
- Attwill Vascular Technologies Inc.Executive Officer, Director
- Attilio Di FioreExecutive Officer, Director, Promoter
- William JacksonExecutive Officer, Director, Promoter
- John SchramDirector
- Offering amount
- $2M
- Amount sold
- $1.7M
- Minimum investment
- $1K
- Sales commissions
- $32.8K
- Placement agents
- ECHELON CAPITAL MARKETS, Leede Jones Gable Inc.
- First sale
- Dec 2021
- Incorporated
- Limited Partnership, Delaware
- Federal exemptions
- 06b, 4a5
▶$1.8MraisedMar 2021 · 25 investors · Other Health CareRule 506(b)
▶$1.8MraisedMar 2021 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ricardo Michael FerreiraDirector
- Richard AbrahamDirector
- Tim ShortlyDirector
- Attilio DiFioreExecutive Officer, Director, Promoter
- Robert Geoffrey BrowneDirector
- John SchramDirector
- William JacksonExecutive Officer, Director, Promoter
- Attwill Vascular Technologies Inc.Executive Officer, Director
- Offering amount
- $1.9M
- Amount sold
- $1.8M
- Minimum investment
- $1K
- Sales commissions
- $35.1K
- Placement agents
- Leede Jones Gable Inc.
- First sale
- Feb 2021
- Incorporated
- Limited Partnership, Delaware, 2016
- Federal exemptions
- 06b, 4a5
▶$1.9MraisedDec 2020 · 14 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2020 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert Geoffrey BrowneDirector
- John SchramDirector
- Tim ShortlyDirector
- Attwill Vascular Technologies Inc.Executive Officer, Director
- William JacksonExecutive Officer, Director, Promoter
- Attilio DiFioreExecutive Officer, Director, Promoter
- Ricardo Michael FerreiraDirector
- Richard AbrahamDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Minimum investment
- $25K
- Sales commissions
- $68.3K
- Placement agents
- Leede Jones Gable Inc.
- First sale
- Nov 2020
- Incorporated
- Limited Partnership, Delaware, 2016
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Attwill Vascular Technologies raised?
- Attwill Vascular Technologies has disclosed $5.4M raised across 3 rounds.
- Where is Attwill Vascular Technologies headquartered?
- Attwill Vascular Technologies is headquartered in Lodi, US.